Author:
Szilágyi Szabolcs,Pollesello Piero,Levijoki Jouko,Kaheinen Petri,Haikala Heimo,Édes István,Papp Zoltán
Reference41 articles.
1. Levosimendan increases L-type Ca2+ current via phosphodiesterase-3 inhibition in human cardiac myocytes;Ajiro;Eur. J. Pharmacol.,2002
2. Mechanisms of the contractile effects of levosimendan in the mammalian heart;Boknik;J. Pharmacol. Exp. Ther.,1997
3. Beneficial effects of the Ca2+ sensitizer levosimendan in human myocardium;Brixius;Am. J. Physiol.,2002
4. Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells;Cone;J. Cardiovasc. Pharmacol.,1999
5. Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds;De Cheffoy de Courcelles;J. Pharmacol. Exp. Ther.,1992
Cited by
109 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献